Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - TOTAL OTHER INCOME
Total Other Income FATE - Fate Therapeutics, Inc.
29.6 M
LAST VALUE
147.15%
2 YEAR CAGR
126.71%
5 YEAR CAGR
27.32%
10 YEAR CAGR